78.35
price up icon2.65%   2.02
after-market After Hours: 78.20 -0.15 -0.19%
loading
Cvs Health Corp stock is traded at $78.35, with a volume of 7.08M. It is up +2.65% in the last 24 hours and down -2.91% over the past month. CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
See More
Previous Close:
$76.33
Open:
$76.37
24h Volume:
7.08M
Relative Volume:
0.88
Market Cap:
$99.46B
Revenue:
$393.94B
Net Income/Loss:
$428.00M
P/E Ratio:
204.78
EPS:
0.3826
Net Cash Flow:
$6.29B
1W Performance:
+5.14%
1M Performance:
-2.91%
6M Performance:
+23.35%
1Y Performance:
+44.45%
1-Day Range:
Value
$76.19
$78.96
1-Week Range:
Value
$73.40
$78.96
52-Week Range:
Value
$53.36
$85.15

Cvs Health Corp Stock (CVS) Company Profile

Name
Name
Cvs Health Corp
Name
Phone
(401) 765-1500
Name
Address
ONE CVS DR., WOONSOCKET
Name
Employee
300,000
Name
Twitter
@cvshealth
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
CVS's Discussions on Twitter

Compare CVS vs UNH, CI, ELV, HUM

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Healthcare Plans icon
CVS
Cvs Health Corp
78.35 96.90B 393.94B 428.00M 6.29B 0.3826
Healthcare Plans icon
UNH
Unitedhealth Group Inc
276.65 243.26B 447.57B 12.81B 16.08B 13.19
Healthcare Plans icon
CI
Cigna Group
292.05 74.96B 216.66B 6.25B 7.44B 22.19
Healthcare Plans icon
ELV
Elevance Health Inc
338.98 73.84B 199.13B 5.66B 3.17B 25.11
Healthcare Plans icon
HUM
Humana Inc
193.94 23.28B 126.36B 1.30B 1.55B 10.67

Cvs Health Corp Stock (CVS) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-14-25 Initiated Goldman Buy
Aug-18-25 Upgrade UBS Neutral → Buy
Aug-14-25 Upgrade Robert W. Baird Neutral → Outperform
Feb-13-25 Upgrade Leerink Partners Market Perform → Outperform
Feb-12-25 Upgrade Cantor Fitzgerald Neutral → Overweight
Jan-30-25 Upgrade Edward Jones Hold → Buy
Dec-03-24 Upgrade Deutsche Bank Hold → Buy
Nov-18-24 Upgrade Wells Fargo Equal Weight → Overweight
Oct-10-24 Upgrade Barclays Equal Weight → Overweight
Oct-04-24 Upgrade TD Cowen Hold → Buy
May-30-24 Initiated Robert W. Baird Neutral
May-07-24 Downgrade TD Cowen Buy → Hold
May-02-24 Downgrade UBS Buy → Neutral
May-01-24 Downgrade Cantor Fitzgerald Overweight → Neutral
May-01-24 Downgrade Leerink Partners Outperform → Market Perform
Mar-06-24 Initiated Barclays Equal Weight
Feb-26-24 Initiated Leerink Partners Outperform
Dec-22-23 Initiated HSBC Securities Buy
Sep-19-23 Upgrade Evercore ISI In-line → Outperform
Sep-12-23 Upgrade Wolfe Research Peer Perform → Outperform
Aug-18-23 Downgrade Edward Jones Buy → Hold
May-26-23 Initiated Piper Sandler Overweight
Apr-21-23 Initiated Cantor Fitzgerald Overweight
Jan-03-23 Downgrade Evercore ISI Outperform → In-line
Nov-23-22 Resumed Morgan Stanley Overweight
Jun-17-22 Initiated Loop Capital Buy
May-27-22 Downgrade Bernstein Outperform → Mkt Perform
Mar-29-22 Downgrade Deutsche Bank Buy → Hold
Feb-11-22 Downgrade Raymond James Strong Buy → Outperform
Dec-14-21 Initiated Goldman Buy
Dec-01-21 Initiated Seaport Research Partners Buy
May-19-21 Initiated Wells Fargo Equal Weight
Mar-17-21 Downgrade Guggenheim Buy → Neutral
Jan-08-21 Upgrade Jefferies Hold → Buy
Sep-17-20 Initiated Piper Sandler Overweight
Jul-01-20 Initiated SVB Leerink Mkt Perform
May-14-20 Upgrade Credit Suisse Neutral → Outperform
Sep-27-19 Resumed RBC Capital Mkts Outperform
Sep-12-19 Initiated Deutsche Bank Buy
Jun-05-19 Upgrade Standpoint Research Hold → Buy
Apr-29-19 Downgrade Credit Suisse Outperform → Neutral
Apr-18-19 Initiated Guggenheim Buy
Apr-15-19 Downgrade Oppenheimer Outperform → Perform
Apr-10-19 Reiterated BofA/Merrill Buy
Mar-13-19 Initiated Bernstein Outperform
Feb-20-19 Downgrade Wells Fargo Outperform → Market Perform
Jan-17-19 Initiated UBS Buy
Dec-18-18 Initiated Barclays Overweight
Nov-29-18 Resumed Goldman Neutral
Nov-28-18 Initiated Evercore ISI Outperform
Oct-26-18 Resumed Wolfe Research Peer Perform
Jul-09-18 Upgrade Citigroup Neutral → Buy
Feb-27-18 Resumed BofA/Merrill Buy
Feb-13-18 Reiterated Citigroup Neutral
View All

Cvs Health Corp Stock (CVS) Latest News

pulisher
06:15 AM

CVS (CVS) Accepts TrumpRx Discount Cards for Prescription Drugs - GuruFocus

06:15 AM
pulisher
04:53 AM

CVS Health (CVS) Embraces TrumpRx Discount Cards for Medication Savings - GuruFocus

04:53 AM
pulisher
04:49 AM

CVS Pharmacy now accepting TrumpRx discount cards - Investing.com

04:49 AM
pulisher
04:08 AM

TrumpRx drug discounts now available at 9,000 CVS pharmacies - stocktitan.net

04:08 AM
pulisher
02:37 AM

CVS Expands Biosimilar Access to Lower Drug Costs - intellectia.ai

02:37 AM
pulisher
01:52 AM

CVS Caremark Replaces Amgen And Eli Lilly's Branded Drugs, Expands Biosimilar Strategy For Weak Bone Disorder - Benzinga

01:52 AM
pulisher
11:29 AM

CVS Specialty brings empathy and expertise to fertility patients - CVS Health

11:29 AM
pulisher
11:00 AM

A Look Into CVS Health Inc's Price Over Earnings - Benzinga

11:00 AM
pulisher
Feb 05, 2026

CVS Faces Medicaid Network Loss And PBM Scrutiny As Valuation Looks Undemanding - simplywall.st

Feb 05, 2026
pulisher
Feb 05, 2026

Aetna, a CVS Health company, receives Health Plan of the Year Award from Press Ganey - CVS Health

Feb 05, 2026
pulisher
Feb 05, 2026

Why Press Ganey named Aetna its first Health Plan of the Year - stocktitan.net

Feb 05, 2026
pulisher
Feb 05, 2026

CVS Health (CVS) Expands Biosimilar Offerings to Cut Costs - GuruFocus

Feb 05, 2026
pulisher
Feb 05, 2026

FTC Settlement With Cigna's Pharmacy Benefit Manager Promises Cheaper Insulin, Boosts Dividend On Strong Quarterly Earnings - Benzinga

Feb 05, 2026
pulisher
Feb 05, 2026

CVS Health to swap Amgen and Lilly’s bone drugs with biosimilars in commercial formularies - Seeking Alpha

Feb 05, 2026
pulisher
Feb 05, 2026

CVS Health to drop Amgen and Lilly's bone disease treatments from some drug lists - Reuters

Feb 05, 2026
pulisher
Feb 05, 2026

Is CVS Health Stock a Bad-News Buy? - AOL.com

Feb 05, 2026
pulisher
Feb 05, 2026

Is CVS Health Stock a Bad-News Buy? - The Motley Fool

Feb 05, 2026
pulisher
Feb 05, 2026

UnitedHealth, CVS, Humana Face Double Trouble As Trump's Medicare Cuts Are Just The Start—PBM 'Spread Pricing' Comes Under Fire - Yahoo Finance

Feb 05, 2026
pulisher
Feb 05, 2026

New CVS drug list swaps Prolia for cheaper osteoporosis shots - stocktitan.net

Feb 05, 2026
pulisher
Feb 05, 2026

Aetna launches simplified, digital-first, benefits onboarding experience for members in 2026 - CVS Health

Feb 05, 2026
pulisher
Feb 04, 2026

CVS Health (CVS) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance Australia

Feb 04, 2026
pulisher
Feb 04, 2026

Cigna settles FTC insulin case, aims to lower drug prices - WTAQ

Feb 04, 2026
pulisher
Feb 04, 2026

Express Scripts Reaches Deal With FTC Over Insulin Pricing Practices - PYMNTS.com

Feb 04, 2026
pulisher
Feb 04, 2026

Cigna settles FTC insulin case, commits to overhauling drug pricing - CNBC

Feb 04, 2026
pulisher
Feb 04, 2026

10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga

Feb 04, 2026
pulisher
Feb 04, 2026

UNH Stock: The Factors Behind UnitedHealth's Struggles in Its Recovery - intellectia.ai

Feb 04, 2026
pulisher
Feb 04, 2026

Exclusive: Cigna settles FTC insulin case, aims to lower drug prices - Reuters

Feb 04, 2026
pulisher
Feb 04, 2026

Four drugs to watch in 2026 that could reshape treatment options - CVS Health

Feb 04, 2026
pulisher
Feb 04, 2026

Wegmans, CVS add SNAP/EBT payments on DoorDash - NJBIZ

Feb 04, 2026
pulisher
Feb 03, 2026

Exclusive-Cigna settles FTC insulin case, commits to overhauling drug pricing - Bitget

Feb 03, 2026
pulisher
Feb 03, 2026

CVS Health: Exploit The Sector Panic Ahead Of Earnings (NYSE:CVS) - Seeking Alpha

Feb 03, 2026
pulisher
Feb 03, 2026

CVS Health (CVS) Expected to Beat Earnings Estimates: Should You Buy? - Finviz

Feb 03, 2026
pulisher
Feb 03, 2026

CVS Health’s (CVS) Path Forward: Policy Challenges, Analyst Views, and Dividend Stability - Insider Monkey

Feb 03, 2026
pulisher
Feb 03, 2026

CVS Health's (CVS) Path Forward: Policy Challenges, Analyst Views, and Dividend Stability - Finviz

Feb 03, 2026
pulisher
Feb 03, 2026

CVS Pharmacy: How America’s Most Convenient Drugstore Quietly Became a Daily-Life Lifesaver - AD HOC NEWS

Feb 03, 2026
pulisher
Feb 02, 2026

Shorts Report: How does CVS Health Corporation correlate with Nasdaq2025 Winners & Losers & Free Technical Pattern Based Buy Signals - baoquankhu1.vn

Feb 02, 2026
pulisher
Jan 31, 2026

CVS Health Corporation (CVS) Positioned for Long-Term Growth Amid Policy Shifts - Finviz

Jan 31, 2026
pulisher
Jan 31, 2026

CVS Health Faces Antitrust Scrutiny As Valuation Flags Undervaluation Risk - Yahoo Finance UK

Jan 31, 2026
pulisher
Jan 31, 2026

Argus Trims CVS Health (CVS) PT to $90 Amid Medicare Advantage Rate Uncertainty - Finviz

Jan 31, 2026
pulisher
Jan 31, 2026

National Pension Service Purchases 119,189 Shares of CVS Health Corporation $CVS - MarketBeat

Jan 31, 2026
pulisher
Jan 30, 2026

Looking Into CVS Health Corp's Recent Short Interest - Benzinga

Jan 30, 2026
pulisher
Jan 30, 2026

AustralianSuper Pty Ltd Sells 492,309 Shares of CVS Health Corporation $CVS - MarketBeat

Jan 30, 2026
pulisher
Jan 30, 2026

AE Wealth Management LLC Has $19.39 Million Stock Position in CVS Health Corporation $CVS - MarketBeat

Jan 30, 2026
pulisher
Jan 29, 2026

US Labor Department proposes rule to boost transparency in pharmacy benefit manager fees - AOL.com

Jan 29, 2026
pulisher
Jan 29, 2026

CVS Health Corporation $CVS Shares Sold by New York State Common Retirement Fund - MarketBeat

Jan 29, 2026
pulisher
Jan 29, 2026

Novare Capital Management LLC Has $398,000 Stake in CVS Health Corporation $CVS - MarketBeat

Jan 29, 2026
pulisher
Jan 29, 2026

CVS Health Corporation $CVS Shares Sold by Bank of New York Mellon Corp - MarketBeat

Jan 29, 2026
pulisher
Jan 29, 2026

CVS Health and Merck Stocks Undervalued, 2026 Revenue Guidance of $400 Billion - Intellectia AI

Jan 29, 2026
pulisher
Jan 29, 2026

CVS Health Corporation (NYSE:CVS) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Jan 29, 2026
pulisher
Jan 29, 2026

CVS Pharmacy Review 2026: Why This Everyday Drugstore Is Quietly Becoming a Health Hub - AD HOC NEWS

Jan 29, 2026
pulisher
Jan 28, 2026

CVS Health (CVS) Ascends While Market Falls: Some Facts to Note - Yahoo Finance

Jan 28, 2026

Cvs Health Corp Stock (CVS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
healthcare_plans CI
$292.05
price up icon 2.64%
healthcare_plans ELV
$338.98
price up icon 2.03%
healthcare_plans HUM
$193.94
price up icon 0.20%
healthcare_plans CNC
$38.46
price down icon 3.66%
healthcare_plans MOH
$131.72
price down icon 25.51%
Cap:     |  Volume (24h):